top of page
Search
Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
Glenn Hearson
Jul 24, 2024
EXHALE-2 Study to assess the efficacy, safety, and tolerability of dexpramipexole in participants with severe eosinophilic asthma
EXHALE-2 Study to assess the efficacy, safety, and tolerability of dexpramipexole in participants with severe eosinophilic asthma
Glenn Hearson
Jul 24, 2024
The C-FIND COPD Study: A Short Information Animation
The C-FIND COPD Study: A Short Information Animation
Glenn Hearson
Jul 18, 2024
Assessment of FucosylGM1 expression in small cell lung carcinoma via antibody (SC134) binding
Assessment of FucosylGM1 expression in small cell lung carcinoma via antibody (SC134) binding
Glenn Hearson
Jun 19, 2024
Study in patients with Rare Cystic Lung Diseases to improve care through clinically relevant research (ORCyD) funded by NIHR Nottingham BRC
Study in patients with Rare Cystic Lung Diseases to improve care through clinically relevant research (ORCyD) funded by NIHR Nottingham BRC
Glenn Hearson
Jun 14, 2024
New £9.4m national research centre will improve tests and treatments for rare lung diseases
New £9.4m national research centre will improve tests and treatments for lung diseases
Glenn Hearson
Apr 25, 2024
Non-invasive Monitoring for non-invasive ventilation: Use of transcutaneous carbon dioxide monitoring: The REACT-CO2 Study
We have recently commenced a new randomised clinical trial led by Dr Milind Sovani at NUH with funding from Radiometer using a skin...
Glenn Hearson
Jan 5, 2024
Efficacy and Safety of Orvepitant in Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis
We have recently commenced a new study led at Nottingham University Hospitals NHS Trust by Gr Gauri Saini, to assess the efficacy and...
Glenn Hearson
Nov 17, 2023
bottom of page